Civica, Inc. (Civica, Civica Rx) announced plans to manufacture and distribute insulins that, once approved, will be available to people with diabetes at significantly lower prices than insulins currently on the market. Dan Liljenquist, Board Chair of Civica Rx and Intermountain Healthcare Chief Strategy Officer calls in to explain what this is and when we will see it become available